findmyKOL
Clinical trialNCT00425750CompletedPhase 2Interventional

Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

SponsorVanderbilt-Ingram Cancer CenterEnrollment25Head and Neck Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Jennie Stuart Medical Center

    Hopkinsville, Kentucky, United States

  • Purchase Cancer Group - Paducah

    Paducah, Kentucky, United States

  • Tennessee Plateau Oncology - Crossville

    Crossville, Tennessee, United States

  • West Tennessee Cancer Center at Jackson-Madison County General Hospital

    Jackson, Tennessee, United States

  • Baptist Regional Cancer Center at Baptist Riverside

    Knoxville, Tennessee, United States

  • Mbccop - Meharry Medical College - Nashville

    Nashville, Tennessee, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2005
Primary completion
30 Jun 2009
Completion
30 Jun 2009
Last update posted
16 Nov 2011
Registered enrollment
25
Registry id
NCT00425750

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.